- Presentations
- 2
- Markets
- 1
Krystexxa is a brand of Pegloticase marketed by Horizon Therapeutics, with 2 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Pegloticase
- Brand owner
- Horizon Therapeutics
- Registered in
- United States
- Strengths and forms
- 8 mg/1 mL injection, 8 mg/50 mL injection
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Krystexxa 8 mg/1 mL injectionIntravenous Cold chain | Horizon Therapeutics | US FDA | Available on request |
| Krystexxa 8 mg/50 mL injectionIntravenous Cold chain | Horizon Therapeutics | US FDA | Available on request |
Brand names and trademarks belong to their owners and are used only to identify products.
Request Krystexxa
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.